Clinical Trial

PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer

Study acronym: PROTECT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 11, 2023 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This prospective, multicenter, nonrandomized phase-II-trial investigates in clinical practice the differences between intensity modulated proton therapy (IMPT) and standard intensity-modulated radiation therapy (IMRT) or volumetric-modulated arc therapy (VMAT) in the effects on dose-volume parameters and treatment-related morbidity for women with locally advanced cervical cancer undergoing chemoradiation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-06-01.
Trial Details
NCT Number NCT05406856
Lead Sponsor Leiden University Medical Center
Collaborators: Erasmus Medical Center, HollandPTC
Conditions Uterine Cervical Neoplasms, Locally Advanced Cervical Carcinoma
Enrollment 30 participants
Start Date 2022-05-02
Primary Completion 2025-07-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2023-10-11